Primary cancer of the fallopian tube. Report of 26 patients

Acta Obstetricia Et Gynecologica Scandinavica
B JereczekA Kobierska

Abstract

Due to rarity of fallopian tube cancer most series on this tumor are small and many problems have remained unsolved. The aim of this report is to review our experience with this neoplasm and to compare it with previously published data. Retrospective study of 26 patients with fallopian tube cancer treated in one institution between 1974 and 1994. All patients underwent primary surgical treatment and 18 received adjuvant therapy including pelvic irradiation in 14 cases and chemotherapy in four. Relapse occurred in 18 out of 25 followed up patients. Upper abdominal component of relapse was encountered in 12 patients (67%), pelvic component - in eight (44%) and extraperitoneal component - six (33%). Pelvic relapse occurred in two out of 13 followed up patients treated with postoperative irradiation and in six out of 12 who did not receive postoperative radiotherapy. Survival ranged from 6 to 218+ months (median 23 months). Five-year actual survival was 33%. There were no 2-year survivors in patients presenting with stage II-IV disease. No correlation was found between tumor grade and survival. Fallopian tube cancer is a treatable disease but cure can be only achieved in patients with early tumor. Postoperative radiotherapy may res...Continue Reading

References

Apr 1, 1992·Acta Obstetricia Et Gynecologica Scandinavica·F Pettersson
Feb 1, 1991·Journal of Clinical Ultrasound : JCU·S Ajjimakorn, Y Bhamarapravati
Dec 15, 1990·Cancer·P G RoseY Tsukada
May 1, 1988·Obstetrics and Gynecology·W A PetersG W Morley
Dec 1, 1987·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M F SchrayG D Malkasian
Nov 1, 1986·Cancer·E H McMurrayA Galakatos
Oct 1, 1986·American Journal of Clinical Oncology·A J JacobsH M Camel
Sep 1, 1971·American Journal of Obstetrics and Gynecology·J G Boutselis, J N Thompson
Aug 1, 1971·Cancer·H M Schiller, S G Silverberg
Jun 1, 1969·Cancer·I Fogh
Jun 1, 1982·Gynecologic Oncology·J A Roberts, S Lifshitz
Sep 15, 1981·American Journal of Obstetrics and Gynecology·H K Tamimi, D C Figge
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A C RosenM Klein
May 1, 1994·Obstetrical & Gynecological Survey·A J Nordin
Aug 1, 1994·International Journal of Cancer. Journal International Du Cancer·A C RosenG W Hacker
Jan 1, 1994·Archives of Gynecology and Obstetrics·A C RosenL Auerbach
Feb 1, 1994·American Journal of Clinical Oncology·D PectasidesA Athanassiou
Mar 1, 1993·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M. BaekelandtJ. Gerris
Mar 1, 1993·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A.Ph. MakarC.G. Tropé
Jan 1, 1950·American Journal of Obstetrics and Gynecology·C Y HUA T HERTIG

❮ Previous
Next ❯

Citations

Jan 20, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A C RosenA Reiner
Mar 18, 1999·Pathology Oncology Research : POR·J Rabczyński, P Ziółkowski
Oct 26, 1999·The Journal of Obstetrics and Gynaecology Research·J W KimJ H Han
Oct 7, 2004·American Journal of Obstetrics and Gynecology·Jurgen M J PiekRené H M Verheijen
May 7, 2003·Cancer·Steven D RoffersCatherine N Correa
Apr 4, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A ObermairL Perrin
Dec 13, 2005·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·A RiskaA Leminen
Feb 21, 2003·International Journal of Cancer. Journal International Du Cancer·Annika RiskaEero Pukkala

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.